Monika Elizabeth Reynolds, MSN, FNP | |
2216 Cornwall Ave, Bellingham, WA 98225 | |
(360) 647-1900 | |
(360) 647-1542 |
Full Name | Monika Elizabeth Reynolds |
---|---|
Gender | Female |
Speciality | Nurse Practitioner - Family |
Location | 2216 Cornwall Ave, Bellingham, Washington |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124509864 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LF0000X | Nurse Practitioner - Family | AP60909299 (Washington) | Primary |
363LF0000X | Nurse Practitioner - Family | 95009122 (California) | Secondary |
Entity Name | Peacehealth |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1356309553 PECOS PAC ID: 9537073960 Enrollment ID: O20031118001062 |
News Archive
Two new studies conducted by Intermountain Healthcare's Intermountain Precision Genomics reveal that precision medicine can improve survival in advanced cancer patients – and do so without increasing costs.
Kinexus Bioinformatics Corporation, a world leader in functional proteomics research, announced the launch of a new peptide synthesis facility to provide researchers with the latest in peptide array technologies. These new services will facilitate and expedite access to peptide platforms for innovative approaches to proteomic research and discovery.
According to the National Institutes of Health, respiratory viruses are the most frequent cause of disease and death in humans, a fact highlighted by the COVID-19 pandemic. Despite the potential to cause severe disease, over 70% of viral infections remain asymptomatic.
Trubion Pharmaceuticals, Inc. today announced Pfizer's decision to discontinue development of TRU-015 (PF-05212374), an investigational drug in Phase 2 evaluation for the treatment of rheumatoid arthritis (RA) developed under the companies' CD20 collaboration. However, Pfizer has confirmed that it will continue to develop SBI-087 (PF-05230895), Trubion's next-generation, humanized, subcutaneous CD20 RA product candidate also in Phase 2 clinical evaluation.
› Verified 6 days ago
Entity Name | Kirstin Curtis Arnp Corp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1669788089 PECOS PAC ID: 5890974851 Enrollment ID: O20110121000901 |
News Archive
Two new studies conducted by Intermountain Healthcare's Intermountain Precision Genomics reveal that precision medicine can improve survival in advanced cancer patients – and do so without increasing costs.
Kinexus Bioinformatics Corporation, a world leader in functional proteomics research, announced the launch of a new peptide synthesis facility to provide researchers with the latest in peptide array technologies. These new services will facilitate and expedite access to peptide platforms for innovative approaches to proteomic research and discovery.
According to the National Institutes of Health, respiratory viruses are the most frequent cause of disease and death in humans, a fact highlighted by the COVID-19 pandemic. Despite the potential to cause severe disease, over 70% of viral infections remain asymptomatic.
Trubion Pharmaceuticals, Inc. today announced Pfizer's decision to discontinue development of TRU-015 (PF-05212374), an investigational drug in Phase 2 evaluation for the treatment of rheumatoid arthritis (RA) developed under the companies' CD20 collaboration. However, Pfizer has confirmed that it will continue to develop SBI-087 (PF-05230895), Trubion's next-generation, humanized, subcutaneous CD20 RA product candidate also in Phase 2 clinical evaluation.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Monika Elizabeth Reynolds, MSN, FNP 1115 Se 164th Ave Dept 358, Vancouver, WA 98683-8004 Ph: (360) 729-1462 | Monika Elizabeth Reynolds, MSN, FNP 2216 Cornwall Ave, Bellingham, WA 98225 Ph: (360) 647-1900 |
News Archive
Two new studies conducted by Intermountain Healthcare's Intermountain Precision Genomics reveal that precision medicine can improve survival in advanced cancer patients – and do so without increasing costs.
Kinexus Bioinformatics Corporation, a world leader in functional proteomics research, announced the launch of a new peptide synthesis facility to provide researchers with the latest in peptide array technologies. These new services will facilitate and expedite access to peptide platforms for innovative approaches to proteomic research and discovery.
According to the National Institutes of Health, respiratory viruses are the most frequent cause of disease and death in humans, a fact highlighted by the COVID-19 pandemic. Despite the potential to cause severe disease, over 70% of viral infections remain asymptomatic.
Trubion Pharmaceuticals, Inc. today announced Pfizer's decision to discontinue development of TRU-015 (PF-05212374), an investigational drug in Phase 2 evaluation for the treatment of rheumatoid arthritis (RA) developed under the companies' CD20 collaboration. However, Pfizer has confirmed that it will continue to develop SBI-087 (PF-05230895), Trubion's next-generation, humanized, subcutaneous CD20 RA product candidate also in Phase 2 clinical evaluation.
› Verified 6 days ago
Melanie R Hartley, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4545 Cordata Pkwy, Suite 1e, Bellingham, WA 98226 Phone: 360-738-2200 Fax: 360-752-5679 | |
Rachel Hill May, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2901 Squalicum Pkwy, Bellingham, WA 98225 Phone: 360-734-5400 | |
Jody L Bauer, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3111 Woburn St Ste 201, Bellingham, WA 98226 Phone: 360-734-1420 Fax: 360-733-1659 | |
David Flarry, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2979 Squalicum Pkwy, Bellingham, WA 98225 Phone: 360-734-2700 | |
Amanda Vichas, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 302 36th St, Bellingham, WA 98225 Phone: 360-756-9793 Fax: 360-752-9007 | |
Graham Meeks, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2979 Squalicum Pkwy Ste 101, Bellingham, WA 98225 Phone: 360-734-2700 Fax: 360-734-8362 | |
Jaspreet S Khehra, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 220 Unity St, Bellingham, WA 98225 Phone: 360-676-6177 |